Nifty
:
14792.75
Sensex
:
49112.32
67.95 (0.46%)
162.56 (0.33%)
Nifty
Sensex
:
:
14792.75
49112.32
67.95 (0.46%)
162.56 (0.33%)

Wockhardt Ltd.

Pharmaceuticals & Drugs - Global

Rating :
55/99

BSE: 532300 | NSE: WOCKPHARMA

NSE BSE
587.80
06-May-2021
  • Open
  • High
  • Low
  • Previous Close
  •  540.00
  •  602.00
  •  534.00
  •  534.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  10151276
  •  58450.59
  •  602.00
  •  210.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6,511.16
  • 7.87
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 9,455.93
  • N/A
  • 1.87

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.12%
  • 0.82%
  • 21.40%
  • FII
  • DII
  • Others
  • 3.1%
  • 0.01%
  • 2.55%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.20
  • -5.67
  • -5.47

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -12.42
  • -13.23
  • 165.87

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.76
  • -
  • -51.54

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.44
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.50
  • 1.96
  • 1.58

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 51.63
  • 75.38
  • 53.43

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Net Sales
764.02
869.15
-12.10%
714.05
682.89
4.56%
598.27
725.58
-17.55%
686.93
861.34
-20.25%
Expenses
708.23
760.01
-6.81%
697.35
670.04
4.08%
670.32
725.98
-7.67%
680.92
847.85
-19.69%
EBITDA
55.79
109.14
-48.88%
16.70
12.85
29.96%
-72.05
-0.40
-
6.01
13.49
-55.45%
EBIDTM
7.30%
12.56%
2.34%
1.88%
-12.04%
-0.06%
0.87%
14.01%
Other Income
103.13
42.26
144.04%
16.24
-0.20
-
7.95
8.08
-1.61%
21.17
26.03
-18.67%
Interest
59.85
78.71
-23.96%
60.90
64.66
-5.82%
73.70
70.91
3.93%
61.44
63.60
-3.40%
Depreciation
67.88
56.27
20.63%
57.15
52.50
8.86%
55.96
54.55
2.58%
60.87
44.65
36.33%
PBT
31.19
16.42
89.95%
-85.11
-104.51
-
-336.24
-117.78
-
-95.13
-68.73
-
Tax
-1.21
-2.79
-
-88.40
11.82
-
-110.66
-54.93
-
-143.86
-41.35
-
PAT
32.40
19.21
68.66%
3.29
-116.33
-
-225.58
-62.85
-
48.73
-27.38
-
PATM
4.24%
2.21%
0.46%
-17.04%
-37.70%
-8.66%
7.09%
7.11%
EPS
1.38
0.87
58.62%
0.32
-8.51
-
68.63
-4.06
-
4.36
28.29
-84.59%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
2,763.27
3,325.15
4,158.38
3,936.90
4,014.61
4,453.22
4,481.54
4,830.36
5,609.42
4,350.50
3,751.24
Net Sales Growth
-11.97%
-20.04%
5.63%
-1.94%
-9.85%
-0.63%
-7.22%
-13.89%
28.94%
15.97%
 
Cost Of Goods Sold
1,104.89
1,203.45
1,636.31
1,797.53
1,662.07
1,613.68
1,487.48
1,806.25
1,747.56
1,534.38
1,516.22
Gross Profit
1,658.38
2,121.70
2,522.07
2,139.37
2,352.54
2,839.54
2,994.06
3,024.11
3,861.86
2,816.12
2,235.02
GP Margin
60.02%
63.81%
60.65%
54.34%
58.60%
63.76%
66.81%
62.61%
68.85%
64.73%
59.58%
Total Expenditure
2,756.82
3,082.03
4,050.63
3,935.07
3,988.39
3,958.98
3,772.14
3,804.65
3,549.74
2,996.79
2,835.28
Power & Fuel Cost
-
85.41
93.30
77.80
110.10
113.99
101.40
92.17
97.08
80.38
55.83
% Of Sales
-
2.57%
2.24%
1.98%
2.74%
2.56%
2.26%
1.91%
1.73%
1.85%
1.49%
Employee Cost
-
743.33
800.38
937.06
966.51
950.77
868.87
768.63
655.90
572.91
542.41
% Of Sales
-
22.35%
19.25%
23.80%
24.07%
21.35%
19.39%
15.91%
11.69%
13.17%
14.46%
Manufacturing Exp.
-
120.90
153.76
135.27
179.40
228.07
236.03
240.85
180.06
115.03
110.79
% Of Sales
-
3.64%
3.70%
3.44%
4.47%
5.12%
5.27%
4.99%
3.21%
2.64%
2.95%
General & Admin Exp.
-
188.20
380.13
476.66
504.43
405.85
320.92
352.19
248.28
194.47
198.73
% Of Sales
-
5.66%
9.14%
12.11%
12.56%
9.11%
7.16%
7.29%
4.43%
4.47%
5.30%
Selling & Distn. Exp.
-
141.18
176.22
208.89
205.30
241.11
261.55
292.98
291.74
214.75
186.16
% Of Sales
-
4.25%
4.24%
5.31%
5.11%
5.41%
5.84%
6.07%
5.20%
4.94%
4.96%
Miscellaneous Exp.
-
599.56
810.53
301.86
360.58
405.51
495.89
251.58
329.12
284.87
186.16
% Of Sales
-
18.03%
19.49%
7.67%
8.98%
9.11%
11.07%
5.21%
5.87%
6.55%
6.00%
EBITDA
6.45
243.12
107.75
1.83
26.22
494.24
709.40
1,025.71
2,059.68
1,353.71
915.96
EBITDA Margin
0.23%
7.31%
2.59%
0.05%
0.65%
11.10%
15.83%
21.23%
36.72%
31.12%
24.42%
Other Income
148.49
60.08
21.02
120.23
100.83
66.10
66.55
38.40
54.00
25.34
152.62
Interest
255.89
275.74
265.14
255.49
225.27
128.96
55.21
83.35
215.37
269.02
267.10
Depreciation
241.86
224.14
163.95
149.53
148.93
141.91
145.40
139.92
122.14
115.07
116.62
PBT
-485.29
-196.68
-300.32
-282.96
-247.15
289.47
575.34
840.84
1,776.17
994.96
684.86
Tax
-344.13
-153.29
-83.66
25.70
-21.11
37.88
162.65
47.88
258.21
221.74
8.65
Tax Rate
70.91%
77.94%
27.86%
-4.01%
8.54%
13.09%
28.27%
5.38%
14.05%
42.54%
8.29%
PAT
-141.16
-69.22
-194.53
-608.30
-195.72
250.08
404.91
840.72
1,579.48
299.45
95.70
PAT before Minority Interest
-177.97
-43.39
-216.66
-666.85
-226.04
251.59
412.69
842.79
1,579.48
299.45
95.70
Minority Interest
-36.81
-25.83
22.13
58.55
30.32
-1.51
-7.78
-2.07
0.00
0.00
0.00
PAT Margin
-5.11%
-2.08%
-4.68%
-15.45%
-4.88%
5.62%
9.04%
17.40%
28.16%
6.88%
2.55%
PAT Growth
0.00%
-
-
-
-
-38.24%
-51.84%
-46.77%
427.46%
212.90%
 
EPS
-12.74
-6.25
-17.56
-54.90
-17.66
22.57
36.54
75.88
142.55
27.03
8.64

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
2,671.67
2,674.80
2,852.15
3,336.71
3,775.12
3,715.35
3,581.47
2,704.18
1,471.02
943.10
Share Capital
55.37
55.34
55.32
55.27
55.25
353.59
353.43
353.34
816.09
799.93
Total Reserves
2,586.33
2,587.19
2,760.11
3,244.43
3,691.22
3,315.65
3,182.73
2,319.30
644.73
143.17
Non-Current Liabilities
1,194.85
1,702.75
2,088.89
3,151.38
1,893.49
1,872.46
1,161.18
1,520.80
2,891.88
2,943.95
Secured Loans
1,237.44
1,653.25
2,167.84
2,887.11
1,647.34
1,180.25
1,096.27
1,467.51
2,697.34
2,785.34
Unsecured Loans
3.46
238.22
5.27
303.16
273.26
4.59
6.03
7.64
9.05
9.15
Long Term Provisions
45.60
53.48
64.89
94.23
70.74
635.05
51.98
69.85
84.49
224.31
Current Liabilities
3,497.18
2,863.66
2,691.71
1,978.81
1,841.85
1,772.97
1,743.20
1,773.48
1,890.94
1,919.01
Trade Payables
895.27
840.24
601.78
533.81
637.69
552.56
557.79
634.15
540.80
436.58
Other Current Liabilities
1,579.80
1,353.09
1,548.13
690.13
621.23
844.44
947.70
789.96
978.38
1,068.86
Short Term Borrowings
903.86
561.71
437.09
662.80
550.03
348.28
210.20
182.00
260.80
390.06
Short Term Provisions
118.25
108.62
104.71
92.07
32.90
27.69
27.51
167.37
110.96
23.51
Total Liabilities
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79
7,504.73
6,622.02
5,998.46
6,253.84
5,806.06
Net Block
3,502.29
3,057.93
2,887.96
2,772.55
2,808.70
2,122.74
2,294.63
1,989.60
2,571.34
2,580.22
Gross Block
6,703.28
6,112.89
5,772.29
5,456.40
4,377.01
4,552.96
4,642.81
4,295.75
4,211.60
4,048.65
Accumulated Depreciation
3,200.99
3,054.96
2,884.33
2,683.85
1,568.31
2,430.22
2,348.18
1,684.94
1,306.76
1,439.10
Non Current Assets
5,319.66
4,756.39
4,598.88
4,313.57
4,023.94
3,983.17
3,266.10
2,671.53
3,772.33
3,903.85
Capital Work in Progress
1,584.53
1,445.48
1,432.57
1,243.95
1,036.05
1,007.30
707.53
490.94
902.29
862.70
Non Current Investment
0.45
0.45
0.45
0.45
0.45
2.62
2.62
2.63
90.75
89.63
Long Term Loans & Adv.
232.39
252.37
277.90
296.62
178.74
845.68
235.86
183.35
207.95
371.30
Other Non Current Assets
0.00
0.16
0.00
0.00
0.00
4.83
25.46
5.01
0.00
0.00
Current Assets
2,429.83
2,814.65
3,379.60
4,535.27
3,951.85
3,521.56
3,355.92
3,326.93
2,481.51
1,902.21
Current Investments
0.00
0.00
213.25
562.27
0.00
338.72
573.98
0.00
0.00
0.00
Inventories
689.83
819.36
855.71
1,107.95
1,102.16
1,020.78
992.89
1,058.83
888.56
713.73
Sundry Debtors
1,242.69
1,273.90
962.45
1,034.45
1,111.42
741.43
481.04
958.46
758.69
605.24
Cash & Bank
268.46
448.65
1,082.25
1,603.61
1,478.11
1,234.55
1,125.80
1,096.06
699.99
482.89
Other Current Assets
228.85
20.18
8.31
29.24
260.16
186.08
182.21
213.58
134.27
100.35
Short Term Loans & Adv.
163.36
252.56
257.63
197.75
260.16
186.08
182.21
213.58
134.27
100.35
Net Current Assets
-1,067.35
-49.01
687.89
2,556.46
2,110.00
1,748.59
1,612.72
1,553.45
590.57
-16.80
Total Assets
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79
7,504.73
6,622.02
5,998.46
6,253.84
5,806.06

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
648.96
183.32
68.44
-269.47
71.61
354.96
1,476.29
1,532.40
1,343.83
641.81
PBT
-196.68
-300.32
-641.15
-247.15
357.01
575.34
890.67
1,860.20
576.72
104.35
Adjustment
483.23
444.52
448.78
303.04
201.29
285.63
133.53
273.31
917.59
495.44
Changes in Working Capital
379.58
80.29
278.33
-297.39
-402.76
-344.62
587.99
-266.99
-129.94
44.99
Cash after chg. in Working capital
666.13
224.49
85.96
-241.50
155.54
516.35
1,612.19
1,866.52
1,364.37
644.78
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-17.17
-41.17
-17.52
-27.97
-83.93
-161.39
-135.90
-334.12
-20.54
-2.97
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-155.53
94.57
630.24
-686.64
-818.19
-206.63
-851.62
1,085.37
-305.45
-276.61
Net Fixed Assets
-499.84
-39.00
-45.55
-166.75
-368.17
-299.87
-283.99
174.15
-181.64
-415.22
Net Investments
0.00
-0.05
0.00
0.00
0.00
10.73
0.00
0.00
0.00
7.69
Others
344.31
133.62
675.79
-519.89
-450.02
82.51
-567.63
911.22
-123.81
130.92
Cash from Financing Activity
-679.58
-776.45
-769.47
1,254.49
254.26
-75.65
-601.32
-2,245.75
-826.56
-372.99
Net Cash Inflow / Outflow
-186.15
-498.56
-70.79
298.38
-492.32
72.68
23.35
372.02
211.82
-7.79
Opening Cash & Equivalents
397.34
897.24
963.64
662.98
1,158.69
1,101.65
1,050.01
689.66
470.10
314.10
Closing Cash & Equivalent
219.34
397.34
897.24
963.64
664.64
1,158.69
1,101.65
1,050.01
689.66
470.10

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
238.55
238.75
254.47
298.51
339.05
306.20
294.97
216.65
63.91
18.08
ROA
-0.57%
-2.79%
-7.93%
-2.69%
3.25%
6.09%
13.36%
25.78%
4.97%
1.67%
ROE
-1.64%
-7.94%
-21.81%
-6.42%
7.07%
12.49%
30.04%
102.78%
66.74%
95.20%
ROCE
1.32%
-0.56%
-5.47%
-0.31%
6.87%
11.25%
18.98%
43.10%
17.39%
8.23%
Fixed Asset Turnover
0.52
0.70
0.70
0.82
1.00
0.98
1.08
1.32
1.05
0.95
Receivable days
138.12
98.15
92.57
97.55
75.93
49.71
54.33
55.81
57.17
57.31
Inventory Days
82.83
73.51
91.03
100.47
87.00
81.88
77.43
63.29
67.16
71.89
Payable days
129.66
86.65
67.29
64.08
64.54
63.71
65.00
65.49
65.74
63.23
Cash Conversion Cycle
91.29
85.01
116.31
133.94
98.39
67.88
66.75
53.61
58.58
65.97
Total Debt/Equity
1.22
1.28
1.33
1.26
0.71
0.55
0.54
0.77
2.25
3.60
Interest Cover
0.29
-0.13
-1.51
-0.10
3.24
11.42
11.69
9.53
2.94
1.39

Annual Reports:

FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011

News Update:


  • Wockhardt gets approval to raise funds upto Rs 150 crore
    22nd Apr 2021, 10:16 AM

    The company’s the Credit Facilities Committee of the Board of Directors at its meeting held on April 21, 2021 has aapproved the same

    Read More
  • Wockhardt planning to raise funds through NCDs
    19th Apr 2021, 11:23 AM

    The meeting of the Credit Facilities Committee of the Board of Directors of the Company is scheduled to be held on April 21, 2021, inter-alia, to consider and approve the same

    Read More
  • Wockhardt awarded six-month extension of agreement with UK Govt to fill-finish COVID-19 vaccines
    10th Feb 2021, 13:14 PM

    This expands the original agreement from 18 to 24 months i.e., until August 2022

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.